» Articles » PMID: 33912076

Role of Podoplanin-Positive Cells in Cardiac Fibrosis and Angiogenesis After Ischemia

Overview
Journal Front Physiol
Date 2021 Apr 29
PMID 33912076
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

New insights into the cellular and extra-cellular composition of scar tissue after myocardial infarction (MI) have been identified. Recently, a heterogeneous podoplanin-expressing cell population has been associated with fibrogenic and inflammatory responses and lymphatic vessel growth during scar formation. Podoplanin is a mucin-like transmembrane glycoprotein that plays an important role in heart development, cell motility, tumorigenesis, and metastasis. In the adult mouse heart, podoplanin is expressed only by cardiac lymphatic endothelial cells; after MI, it is acquired with an unexpected heterogeneity by PDGFRα-, PDGFRβ-, and CD34-positive cells. Podoplanin may therefore represent a sign of activation of a cohort of progenitor cells during different phases of post-ischemic myocardial wound repair. Podoplanin binds to C-type lectin-like receptor 2 (CLEC-2) which is exclusively expressed by platelets and a variety of immune cells. CLEC-2 is upregulated in CD11b cells, including monocytes and macrophages, following inflammatory stimuli. We recently published that inhibition of the interaction between podoplanin-expressing cells and podoplanin-binding cells using podoplanin-neutralizing antibodies reduces but does not fully suppress inflammation post-MI while improving heart function and scar composition after ischemic injury. These data support an emerging and alternative mechanism of interactome in the heart that, when neutralized, leads to altered inflammatory response and preservation of cardiac function and structure. The overarching objective of this review is to assimilate and discuss the available evidence on the functional role of podoplanin-positive cells on cardiac fibrosis and remodeling. A detailed characterization of cell-to-cell interactions and paracrine signals between podoplanin-expressing cells and the other type of cells that compose the heart tissue is needed to open a new line of investigation extending beyond the known function of these cells. This review attempts to discuss the role and biology of podoplanin-positive cells in the context of cardiac injury, repair, and remodeling.

Citing Articles

Bibliometrics of trends in global research on the roles of stem cells in myocardial fibrosis therapy.

Ding J, Meng T, Du R, Song X, Li Y, Gao J World J Stem Cells. 2024; 16(12):1086-1105.

PMID: 39734477 PMC: 11669986. DOI: 10.4252/wjsc.v16.i12.1086.


Understanding the Foreign Body Response via Single-Cell Meta-Analysis.

Liang N, Parker J, Lu J, Januszyk M, Wan D, Griffin M Biology (Basel). 2024; 13(7).

PMID: 39056733 PMC: 11273435. DOI: 10.3390/biology13070540.


Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis.

Rosa I, Romano E, Fioretto B, El Aoufy K, Bellando-Randone S, Matucci-Cerinic M Cells. 2023; 12(17).

PMID: 37681927 PMC: 10486460. DOI: 10.3390/cells12172195.


The ebb and flow of cardiac lymphatics: a tidal wave of new discoveries.

Harris N, Balint L, Dy D, Nielsen N, Mendez H, Aghajanian A Physiol Rev. 2022; 103(1):391-432.

PMID: 35953269 PMC: 9576179. DOI: 10.1152/physrev.00052.2021.


Full spectrum flow cytometry reveals mesenchymal heterogeneity in first trimester placentae and phenotypic convergence in culture, providing insight into the origins of placental mesenchymal stromal cells.

Boss A, Damani T, Wickman T, Chamley L, James J, Brooks A Elife. 2022; 11.

PMID: 35920626 PMC: 9371602. DOI: 10.7554/eLife.76622.


References
1.
Hirakawa S, Hong Y, Harvey N, Schacht V, Matsuda K, Libermann T . Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol. 2003; 162(2):575-86. PMC: 1851142. DOI: 10.1016/S0002-9440(10)63851-5. View

2.
Song Y, Shen J, Lin Y, Shen J, Wu X, Yan Y . Up-regulation of podoplanin involves in neuronal apoptosis in LPS-induced neuroinflammation. Cell Mol Neurobiol. 2014; 34(6):839-49. PMC: 11488876. DOI: 10.1007/s10571-014-0060-y. View

3.
Groger M, Loewe R, Holnthoner W, Embacher R, Pillinger M, Herron G . IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J Immunol. 2004; 173(12):7161-9. DOI: 10.4049/jimmunol.173.12.7161. View

4.
Martin-Villar E, Borda-dAgua B, Carrasco-Ramirez P, Renart J, Parsons M, Quintanilla M . Podoplanin mediates ECM degradation by squamous carcinoma cells through control of invadopodia stability. Oncogene. 2014; 34(34):4531-44. PMC: 4430312. DOI: 10.1038/onc.2014.388. View

5.
Nakazawa Y, Takagi S, Sato S, Oh-Hara T, Koike S, Takami M . Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies. Cancer Sci. 2011; 102(11):2051-7. PMC: 11159832. DOI: 10.1111/j.1349-7006.2011.02058.x. View